| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |